Longevity & Cellular

Glutathione

Reduced glutathione (γ-L-glutamyl-L-cysteinyl-glycine)

Glutathione is a tripeptide antioxidant that maintains the body's internal redox balance and protects cells from oxidative damage. Research studies it for metabolic, lung, and neurodegenerative conditions, with the strongest human data on sublingual administration.

Glutathione

Reduced glutathione (γ-L-glutamyl-L-cysteinyl-glycine)
Antioxidant / Redox Modulator
Research Only

Half-Life

Not established

Route

Oral, sublingual, injectable (IM/SQ/IV), inhaled

Typical Dose

Sublingual 100–400 mg daily; injectable 100–200 mg 2–3 times weekly

Mechanism / Target

GSH/GSSG redox buffer; glutathione peroxidases including GPX4; SLC7A11/GPX4 ferroptosis axis

Evidence Level

Human crossover RCT for biomarker endpoints; otherwise mostly preclinical and observational

Primary Research Use

Antioxidant and cellular redox support; studied for metabolic syndrome, cystic fibrosis, and Parkinson's disease

Mechanism: Glutathione directly scavenges reactive oxygen species and serves as the reducing cofactor for antioxidant enzymes such as glutathione peroxidase 4, helping keep the cellular environment in a reduced state.

This information is for research only. Not intended for human use.

Overview

Glutathione is a small tripeptide made from three amino acids: glutamate, cysteine, and glycine. It is the main low-molecular-weight thiol inside aerobic cells and acts as the principal intracellular redox buffer . In plain terms, it is the cell's key water-soluble antioxidant and helps keep oxidation in check.

Most of the body's glutathione is made in the liver and exported into the blood, where other tissues can take it up or break it down . Reduced glutathione (GSH) is the active form. When it neutralizes an oxidant, two GSH molecules link into oxidized glutathione disulfide (GSSG), and the GSH/GSSG ratio becomes a standard marker of cellular redox state . A falling ratio usually means more oxidative stress.

Research examines glutathione across conditions tied to oxidative stress, including metabolic syndrome , cystic fibrosis , Parkinson's disease , cancer redox biology , and age-related hearing loss . The human evidence is strongest for sublingual glutathione, while most other uses rest on preclinical or observational work.

How it works

Glutathione works mainly as a redox buffer. It directly neutralizes reactive oxygen and nitrogen species, which are unstable molecules that can damage DNA, proteins, and lipids . The reduced form, GSH, donates electrons. Once it handles an oxidant, two GSH molecules form oxidized GSSG, and the enzyme glutathione reductase recycles GSSG back to GSH using NADPH .

Three enzyme families depend on GSH: glutathione peroxidases (GPx), glutathione S-transferases (GSTs), and glutaredoxins . One member, GPX4, is a selenium-containing enzyme that reduces lipid hydroperoxides in cell membranes . This step helps prevent ferroptosis, an iron-dependent form of cell death driven by lipid peroxidation .

The system is fed by the cystine/glutamate antiporter SLC7A11, which imports cystine. Cells convert cystine to cysteine, the rate-limiting building block for glutathione synthesis . The first synthesis step is controlled by glutamate-cysteine ligase (GCL) . Glutathione is then made in the cytosol and imported into mitochondria, where a transport protein called SLC25A39 is regulated by iron-sulfur status . Because cysteine is usually the limiting ingredient, precursors like N-acetylcysteine (NAC) and γ-glutamylcysteine (GGC) are studied as ways to raise glutathione .

Documented effects

Documented effects vary by evidence strength. The strongest human data come from a small crossover trial, while many disease-related findings are preclinical or observational.

  • Redox markers in humans: In 20 adults with metabolic syndrome, 21 days of sublingual glutathione increased plasma total and reduced glutathione and the GSH/GSSG ratio more than oral glutathione or NAC. It also raised plasma vitamin E . Hard clinical outcomes were not measured.
  • Cystic fibrosis: A small open pilot found that inhaled buffered glutathione was associated with clinical status improvement in people with cystic fibrosis .
  • Cellular protection: In vitro, γ-glutamylcysteine (GGC) restored glutathione and reduced inflammatory markers in amyloid-stressed astrocytes . In a mouse sepsis model, GGC reduced lethality and inflammatory mediators more than NAC or glutathione .
  • Disease associations: Low glutathione and low GPx activity were observed in colon cancer patients compared with controls . In presbycusis, high GPx with low GSH/GSSG ratio was linked to hearing loss . Parkinson's disease is consistently associated with lowered nigral glutathione and GSH/GSSG ratio, though causality is unresolved .
  • Ferroptosis regulation: Loss of the SLC7A11/GSH/GPX4 axis triggers ferroptosis. In vascular smooth muscle cells, repression of this axis drove ferroptosis and vascular calcification .
  • Aging: Glutathione levels decline with aging, and unusually high levels in healthy elderly people suggest a possible healthspan marker .

Research protocols

Research protocols for glutathione vary by route. The most controlled human data are for sublingual glutathione. A 3-week randomized crossover trial in 20 adults with metabolic syndrome found that daily sublingual glutathione improved plasma redox markers compared with oral glutathione and NAC . The exact sublingual dose was not abstracted, but community protocols often use 100–400 mg per day.

RouteTypical research doseFrequencyEvidence
Sublingual glutathione100–400 mg/dayDailyHuman crossover [source:1]
Oral glutathione250–1000 mg/dayDailyLow oral bioavailability [source:1][source:2]
Liposomal oral glutathione250–500 mg/dayDailyCommunity protocol; no controlled human data
Injectable IM/SQ100–200 mg2–3 times weeklyCommunity protocol
IV glutathione600–1200 mgOnce weeklyPractitioner consensus
Inhaled buffered glutathioneNot reportedVariableCystic fibrosis pilot [source:11]

This information is for research only. Not intended for human use.

Community injectable protocols sometimes scale around 1–2 mg/kg per IM/SQ dose, but this is not derived from randomized trials. No controlled data define the best time of day. Community practice uses oral or sublingual glutathione on an empty stomach or 20–30 minutes before meals, while injectable glutathione has no meal restriction.

Controlled data cover only 3 weeks of sublingual use . Community protocols often run injectable glutathione 8–12 weeks, followed by 4 weeks off. Onset for sublingual glutathione was measured at the 3-week endpoint, and community reports with injectable use often describe subjective effects within 1–2 weeks.

Studied protocol

GlutathioneSystemic antioxidant support · Intramuscular
1

Loading

100–200 mg2–3 times weekly4 weeks

Community protocols often start at the lower end to assess tolerability.

2

Primary phase

100–200 mg2–3 times weekly4–8 weeks

No controlled human data for injectable glutathione; this reflects practitioner consensus.

This information is for research only. Not intended for human use.

Reconstitution and storage

Reduced glutathione is oxidation-sensitive, so handling matters. Use sterile bacteriostatic water or sterile saline for injection as the diluent. Add the diluent gently down the vial wall and swirl rather than shaking, because the free thiol group oxidizes easily .

Lyophilized glutathione should be stored frozen at −20°C for long-term stability or refrigerated at 2–8°C for short-term use, protected from light and moisture. After reconstitution, keep the solution refrigerated at 2–8°C and use within 24–72 hours because aqueous glutathione autoxidizes to GSSG .

Draw immediately after reconstitution when possible. Do not freeze the reconstituted solution. The interactive calculator above handles concentration and dose math, but the qualitative guidance is simple: protect the thiol group from air, heat, and agitation.

mg
ml
mg
Concentration
2000 mcg per unit
Doses per vial
6

100 mg = 50 units · 0.5 ml

50 units on a U-100 syringe

This information is for research only. Not intended for human use.

Open the full Glutathione calculator

Interactions

Glutathione's central role in drug detoxification means several interactions are mechanistically plausible, although human interaction trials are limited.

  • Platinum and alkylating chemotherapy: Elevated intracellular glutathione and glutathione S-transferase activity correlate with resistance to cisplatin, carboplatin, and melphalan in ovarian cancer cell lines . High-dose glutathione during platinum therapy may blunt efficacy.
  • Acetaminophen: Glutathione detoxifies the reactive NAPQI metabolite. The acetaminophen–glutathione conjugate inhibits glutathione reductase . Glutathione support is not a substitute for standard overdose care.
  • Ferroptosis-inducing cancer therapies: Because GSH and GPX4 protect cells from lipid peroxidation, glutathione supplementation may theoretically oppose ferroptosis-dependent treatments .
  • Glutathione-depleting agents: Buthionine sulfoximine and ebselen act partly by lowering glutathione, so concurrent high-dose glutathione may oppose these effects .
  • Copper: Excess glutathione with free copper can form redox-active complexes that generate superoxide . High-dose glutathione in copper overload may be problematic.
  • Selenium: GPX4 is a selenoprotein, so selenium adequacy is required for glutathione-dependent peroxide detoxification .
  • NAC and GGC: NAC is a cysteine prodrug, and GGC bypasses the GCL regulation step to raise glutathione .
  • Vitamin C, vitamin E, and alpha-lipoic acid: These regenerate or spare glutathione, with no documented adverse interaction .

Stacking

No formal peptide interaction studies for glutathione were identified in the source corpus. Community protocols often combine injectable glutathione with vitamin C, NAD+, and amino acid blends without reported antagonism.

  • NAC plus glycine: Glycine and NAC are studied together to support glutathione synthesis because cysteine and glycine are both precursors .
  • Selenium plus glutathione: This pairing is mechanistically rational because GPX4 is a selenoprotein .
  • Vitamin C and vitamin E: Both can regenerate or spare glutathione, and a human crossover found sublingual glutathione raised plasma vitamin E .
  • Copper peptides such as GHK-Cu: Theoretical redox cycling with copper and glutathione may increase oxidative stress, so research protocols often separate them by at least 1 hour .
  • Nrf2 activators: Compounds like sulforaphane upregulate glutathione synthesis, so they may add to glutathione support, though cancer patients should avoid unmonitored combinations .

Regulatory status

Glutathione is not FDA-approved as a prescription drug for these indications. In the United States, oral glutathione is sold as a dietary supplement, but injectable glutathione is compounded and used off-label in practitioner settings. Injectable routes cannot lawfully be marketed as supplements.

Internationally, glutathione injection is generally unregistered as a medicine. It may be available through pharmacy compounding or unlicensed specials in some countries, but consumer import of injectables is often restricted.

Glutathione is not named on the WADA Prohibited List. However, intravenous infusions or injections above 100 mL per 12-hour period are banned as a method unless a therapeutic use exemption applies. Athletes using IV glutathione without a TUE risk an anti-doping rule violation independent of the substance's status.

Safety and side effects

Short-term oral and sublingual glutathione appear well tolerated. A 3-week crossover in adults with metabolic syndrome reported no limiting safety signal . Oral glutathione has low bioavailability, and doses above roughly 1000 mg/day can cause bloating, loose stools, or sulfur burps.

Inhaled glutathione may provoke bronchospasm in sensitive individuals . Practitioner reports note transient injection-site reactions, flushing, and mild headache with IV or IM glutathione. Rapid IV or IM administration may cause nausea or transient low blood pressure.

Cancer is the main caution. Glutathione supports tumor antioxidant defenses and is linked to chemoresistance . Because GSH is required for GPX4 to suppress ferroptosis, raising glutathione could theoretically protect cancer cells . Research protocols generally avoid supplemental glutathione during active pro-oxidant cancer treatment unless supervised by oncology.

Long-term safety beyond about 12 weeks is not established, and most human trials are 3 weeks or shorter . The impact of sustained glutathione elevation on occult malignancy or recurrence risk remains unknown.

Frequently asked questions

Is glutathione FDA-approved?+

Glutathione is not approved by the U.S. FDA as a prescription drug for most indications. It is sold as an oral dietary supplement and used as a compounded injectable in practitioner settings (community protocol). Regulatory status varies internationally.

Is injectable/subcutaneous glutathione better than oral?+

Oral GSH has poor plasma bioavailability; in a human crossover RCT, sublingual GSH significantly raised total/reduced plasma GSH and the GSH/GSSG ratio compared with oral GSH, and improved plasma vitamin E after 3 weeks. Injectable routes bypass first-pass degradation and likely produce higher exposure, but direct head-to-head human pharmacokinetic trials are lacking (community protocol). For high-dose clinical use, intramuscular, subcutaneous, or IV routes are typical; for daily maintenance, sublingual or liposomal oral forms are more practical.

What dose and schedule are used for injectable glutathione?+

There is no FDA-approved injectable dose. Common practitioner protocols use 100–200 mg intramuscular or subcutaneous 2–3 times weekly, or 600–1200 mg IV once weekly for 4–8 weeks, followed by tapered maintenance at 1–2 times monthly (community protocol). Oral/liposomal protocols often use 250–500 mg/day; sublingual glutathione is commonly used in the range of 100–400 mg/day (community protocol).

Can I use glutathione while pregnant or breastfeeding?+

No adequate human pregnancy or lactation safety data exist for supplemental or injectable glutathione. Endogenous GSH is essential for cellular redox balance and transport, but pharmacological dosing has not been tested for reproductive safety. Avoid use during pregnancy and lactation unless under direct specialist care and with explicit risk/benefit assessment (community protocol).

How long can I take glutathione? Should I cycle?+

No long-term RCTs define a maximum duration. GSH synthesis and cellular uptake are tightly autoregulated, but tissue GSH levels decline with aging and chronic disease. In the absence of long-term safety data, practitioner consensus commonly cycles injectable GSH 8–12 weeks on, 2–4 weeks off, or uses a loading phase followed by maintenance 1–2 times monthly (community protocol).

How does glutathione compare to NAC or γ-glutamylcysteine?+

In the only direct human crossover RCT, sublingual GSH produced greater increases in total/reduced plasma GSH and the GSH/GSSG ratio than oral GSH or NAC. γ-Glutamylcysteine (GGC) bypasses the rate-limiting glutamate cysteine ligase step; in human astrocyte cultures it restored GSH and increased antioxidant enzymes, and in a mouse sepsis model it showed stronger anti-inflammatory effect than NAC or GSH. NAC has the largest human safety record; GSH offers direct administration; GGC is promising but least tested in humans (community protocol).

Does injectable glutathione need to be refrigerated?+

Compounded injectable GSH should be refrigerated at 2–8°C, protected from light, and used promptly after reconstitution because reduced GSH is oxidation-sensitive. Oral and sublingual forms should be stored cool and dry. For travel, use an insulated cooler with cold packs (community protocol).

References

  1. 1.Effects of N-acetylcysteine, oral glutathione (GSH) and a novel sublingual form of GSH on oxidative stress markers: A comparative crossover studySchmitt, et al. · 2015
  2. 2.How to Increase Cellular GlutathioneGiustarini, et al. · 2023
  3. 3.Glutathione and Glutathione-dependent Enzymes: From Biochemistry to Gerontology and Successful AgingLapenna · 2023
  4. 4.Autoregulatory control of mitochondrial glutathione homeostasisLiu, et al. · 2023
  5. 5.The Selenoprotein Glutathione Peroxidase 4: From Molecular Mechanisms to Novel Therapeutic OpportunitiesWeaver, et al. · 2022
  6. 6.Repression of the antiporter SLC7A11/Glutathione/Glutathione Peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcificationYe, et al. · 2022
  7. 7.The Precursor to Glutathione (GSH), γ-Glutamylcysteine (GGC), Can Ameliorate Oxidative Damage and Neuroinflammation Induced by Aβ40 Oligomers in Human AstrocytesBraidy, et al. · 2019
  8. 8.γ-glutamylcysteine exhibits anti-inflammatory effects by increasing cellular glutathione levelYang, et al. · 2019
  9. 9.The glutathione system in Parkinson's disease and its progressionBjørklund, et al. · 2021
  10. 10.Glutathione Peroxide and Glutathione to Disulfide Glutathione Ratio in Presbycusis: a Case-control StudyHasansulama, et al. · 2022
  11. 11.A pilot study of the effect of inhaled buffered reduced glutathione on the clinical status of patients with cystic fibrosisBishop, et al. · 2005
  12. 12.Glutathione-Dependent Pathways in Cancer CellsKalinina · 2024
  13. 13.The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19Silvagno, et al. · 2020
  14. 14.Determination of glutathione peroxidase activity and oxidized/reduced glutathione ratio in patients with colon cancerGÖKCE Kemal, et al. · 2023
  15. 15.The Glutathione System: A Journey from Cyanobacteria to Higher EukaryotesCassier-Chauvat, et al. · 2023
  16. 16.Cellular Compartmentalization, Glutathione Transport and Its Relevance in Some PathologiesVázquez-Meza, et al. · 2023
  17. 17.Endogenous formaldehyde scavenges cellular glutathione resulting in redox disruption and cytotoxicityUmansky, et al. · 2022
  18. 18.Elucidating the contribution of mitochondrial glutathione to ferroptosis in cardiomyocytesJang, et al. · 2021
  19. 19.Glutathione Participation in the Prevention of Cardiovascular DiseasesMatuz-Mares, et al. · 2021
  20. 20.The antioxidant glutathioneD. Averill-Bates · 2023
  21. 21.Unraveling the Potential Role of Glutathione in Multiple Forms of Cell Death in Cancer TherapyLv, et al. · 2019
  22. 22.The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinomaMiess, et al. · 2018
  23. 23.Redox-implications associated with the formation of complexes between copper ions and reduced or oxidized glutathioneAliaga, et al. · 2016
  24. 24.Evaluation of oxidative stress biomarkers for differentiating bacterial and viral infections: a comparative study of glutathione disulfide (GSSG) and reduced glutathione (GSH)Milhelm, et al. · 2024
  25. 25.Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseasesAllocati, et al. · 2018
  26. 26.The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell linesMistry, et al. · 1991
  27. 27.Ebselen exerts antifungal activity by regulating glutathione (GSH) and reactive oxygen species (ROS) production in fungal cellsThangamani, et al. · 2016
  28. 28.Glutathione (GSH) conjugates with dopamine (DA)-derived quinones to form reactive or non-reactive GSH-conjugatesZhou, et al. · 2009
  29. 29.Superoxide-dependent depletion of reduced glutathione by L-DOPA and dopamine. Relevance to Parkinson's diseaseSpencer, et al. · 1995
  30. 30.Comparison of inhibitory effects between acetaminophen–glutathione conjugate and reduced glutathione in human glutathione reductaseNýdlová, et al. · 2013
  31. 31.Simultaneous analysis of reduced glutathione and glutathione disulfide by capillary zone electrophoresisHempe, et al. · 2014
  32. 32.Measurement of Glutathione and Glutathione DisulfideMustacich · 1999
  33. 33.Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridineGriffith · 1980
  34. 34.A colorimetric method to measure oxidized, reduced and total glutathione levels in erythrocytesAlisik, et al. · 2019
  35. 35.The assessment of glutathione, glutathione peroxidase, glutathione reductase, and oxidized glutathione in patients with periodontitis—A systematic review and meta-analysisMohideen, et al. · 2024
  36. 36.GSH-related enzyme activity and tumor relation: glutathione peroxidase and glutathione reductase status under hypoxia in HepG2 cellsOzensoy Guler, et al. · 2024
  37. 37.PLASMA LEVELS OF REDUCED(GSH) OR OXIDIZED (GSSG) GLUTATHIONE DO NOT ACCURATELY REFLECT TISSUE GSH AND GSSG CHANGES CAUSED BY OXIDANT STRESSIkegami, et al. · 1994

Last reviewed on Aug 22, 2026

Have more questions about Glutathione?

Ask ChatPEP for protocols, stacking, and cited research tailored to your goals.